These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15302863)

  • 1. Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?
    Mareeva T; Lebedeva T; Anikeeva N; Manser T; Sykulev Y
    J Biol Chem; 2004 Oct; 279(43):44243-9. PubMed ID: 15302863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.
    Tong JC; Kong L; Tan TW; Ranganathan S
    Appl Bioinformatics; 2006; 5(2):111-4. PubMed ID: 16722775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.
    Cole DK; Miles KM; Madura F; Holland CJ; Schauenburg AJ; Godkin AJ; Bulek AM; Fuller A; Akpovwa HJ; Pymm PG; Liddy N; Sami M; Li Y; Rizkallah PJ; Jakobsen BK; Sewell AK
    J Biol Chem; 2014 Jan; 289(2):628-38. PubMed ID: 24196962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the Conformational Dynamics of Affinity-Enhanced T Cell Receptor Variants upon Binding the Peptide-Bound Major Histocompatibility Complex by Hydrogen/Deuterium Exchange Mass Spectrometry.
    Merkle PS; Trabjerg E; Hongjian S; Ferber M; Cuendet MA; Jørgensen TJD; Luescher I; Irving M; Zoete V; Michielin O; Rand KD
    Biochemistry; 2021 Mar; 60(11):859-872. PubMed ID: 33689297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.
    Liu YC; Chen Z; Burrows SR; Purcell AW; McCluskey J; Rossjohn J; Gras S
    J Biol Chem; 2012 Apr; 287(15):12267-76. PubMed ID: 22343629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 kinetically promotes ligand binding to the T-cell antigen receptor.
    Gakamsky DM; Luescher IF; Pramanik A; Kopito RB; Lemonnier F; Vogel H; Rigler R; Pecht I
    Biophys J; 2005 Sep; 89(3):2121-33. PubMed ID: 15980174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.
    Carreño LJ; Bueno SM; Bull P; Nathenson SG; Kalergis AM
    Immunology; 2007 Jun; 121(2):227-37. PubMed ID: 17313485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.
    Dhusia K; Su Z; Wu Y
    Mol Immunol; 2021 Nov; 139():76-86. PubMed ID: 34455212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics.
    Persaud SP; Donermeyer DL; Weber KS; Kranz DM; Allen PM
    Mol Immunol; 2010 May; 47(9):1793-801. PubMed ID: 20334923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.
    Salutari I; Martin R; Caflisch A
    Proteins; 2020 Jan; 88(1):31-46. PubMed ID: 31237711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.
    Hawse WF; De S; Greenwood AI; Nicholson LK; Zajicek J; Kovrigin EL; Kranz DM; Garcia KC; Baker BM
    J Immunol; 2014 Mar; 192(6):2885-91. PubMed ID: 24523505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study.
    Wolfson MY; Nam K; Chakraborty AK
    J Phys Chem B; 2011 Jun; 115(25):8317-27. PubMed ID: 21651302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.
    Huppa JB; Axmann M; Mörtelmaier MA; Lillemeier BF; Newell EW; Brameshuber M; Klein LO; Schütz GJ; Davis MM
    Nature; 2010 Feb; 463(7283):963-7. PubMed ID: 20164930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition.
    Seibel JL; Wilson N; Kozono H; Marrack P; Kappler JW
    J Exp Med; 1997 Jun; 185(11):1919-27. PubMed ID: 9166421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.
    Adams JJ; Narayanan S; Liu B; Birnbaum ME; Kruse AC; Bowerman NA; Chen W; Levin AM; Connolly JM; Zhu C; Kranz DM; Garcia KC
    Immunity; 2011 Nov; 35(5):681-93. PubMed ID: 22101157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.